Connaughton Bernadette Insider Trades

Insider Trading History

Track insider trading activity for Connaughton Bernadette. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $3.24M 45,294 shares
Last Trade
May 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$846k 12,836 shares
$65.87
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $2.76M 38,498 shares
Last Trade
May 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$103k 1,625 shares
$63.48
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $2.87M 40,123 shares
Last Trade
Jan 05, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$141k 2,000 shares
$70.25
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $3.02M 42,123 shares
Last Trade
Dec 01, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$59.4k 829 shares
$71.60
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $3.08M 42,952 shares
Last Trade
Nov 10, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$137k 2,000 shares
$68.48
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $3.25M 45,452 shares
Last Trade
Oct 01, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$150k 2,000 shares
$75.24
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $3.64M 50,852 shares
Last Trade
Sep 02, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$295k 4,000 shares
$73.69
$71.60
Editas Medicine
Editas Medicine EDIT
Director
Holding Value $112k 37,500 shares
Last Trade
Jun 06, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$71.6k 37,500 shares
$1.91
$2.99
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $3.65M 50,952 shares
Last Trade
May 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$345k 5,750 shares
$60.03
$71.60
Editas Medicine
Editas Medicine EDIT
Director
Holding Value $74.8k 25,000 shares
Last Trade
May 30, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$129k 25,000 shares
$5.17
$2.99
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $3.35M 46,787 shares
Last Trade
Apr 25, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$339k 8,804 shares
$38.46
$71.60
Syneos Health
Syneos Health SYNH
Director
Holding Value $209k 4,863 shares
Last Trade
Sep 28, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$426k 9,915 shares
$43.00
$42.98
Editas Medicine
Editas Medicine EDIT
Director
Holding Value $74.8k 25,000 shares
Last Trade
Jun 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$239k 25,000 shares
$9.55
$2.99
Syneos Health
Syneos Health SYNH
Director
Holding Value $635k 14,778 shares
Last Trade
May 25, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$202k 4,863 shares
$41.58
$42.98
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $2.88M 40,286 shares
Last Trade
May 05, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$353k 11,371 shares
$31.00
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $2.31M 32,221 shares
Last Trade
Nov 16, 2022 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$320k 5,998 shares
$53.27
$71.60
Editas Medicine
Editas Medicine EDIT
Director
Holding Value $74.8k 25,000 shares
Last Trade
Jun 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$308k 25,000 shares
$12.31
$2.99
Syneos Health
Syneos Health SYNH
Director
Holding Value $426k 9,915 shares
Last Trade
May 25, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$201k 2,839 shares
$70.72
$42.98
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $2.74M 38,219 shares
Last Trade
May 05, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$250k 6,206 shares
$40.29
$71.60
Editas Medicine
Editas Medicine EDIT
Director
Holding Value $73.9k 24,732 shares
Last Trade
Oct 26, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$937k 24,732 shares
$37.90
$2.99

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up